Kyle Gano
Vermogen: 22 M $ op 30-09-2026
Vermogen: 22 M $ op 30-09-2026
Kyle W.
Gano is currently President, Chief Executive Officer & Director at Neurocrine Biosciences, Inc. since 2024.
Dr. Gano is also a Director at Pharmaceutical Research & Manufacturers of America since 2024.
Education history includes an undergraduate degree from the University of Washington in 1996, an MBA and a doctorate from the University of California, Los Angeles, and an undergraduate degree from the University of Oregon.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-09-2026 | 154.728 ( 0,15% ) | 22 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Algemeen Directeur | 11-10-2024 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Bestuurslid | 01-10-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau